{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:22:51Z","timestamp":1787660571304,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.08.021","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:16:55Z","timestamp":1786637815000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["DC vaccine loaded with Bacteroides fragilis elicits functional cross-reactivity and enhances anti-PD-1 immunotherapy"],"prefix":"10.1016","author":[{"given":"Shichuan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6842-7463","authenticated-orcid":false,"given":"Liansha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4885-5481","authenticated-orcid":false,"given":"Jiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.08.021_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-020-00862-w","article-title":"Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy","volume":"13","author":"Pan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.021_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2026.08.021_bib4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1126\/science.aar6918","article-title":"The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies","volume":"359","author":"Zitvogel","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.021_bib5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.021_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.021_bib7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.021_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","article-title":"Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects","volume":"45","author":"Daill\u00e8re","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.08.021_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.021_bib10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.021_bib11","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.021_bib12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.chom.2023.03.020","article-title":"Key determinants of success in fecal microbiota transplantation: From microbiome to clinic","volume":"31","author":"Porcari","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2026.08.021_bib13","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.08.021_bib14","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2017.08.022","article-title":"Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice","volume":"153","author":"Wong","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2026.08.021_bib15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1126\/science.aax0701","article-title":"Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage","volume":"369","author":"Fluckiger","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.021_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135597","article-title":"Commensal bacteria stimulate antitumor responses via T cell cross-reactivity","volume":"5","author":"Bessell","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.08.021_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cell.2016.03.001","article-title":"Microbiome and Anticancer Immunosurveillance","volume":"165","author":"Zitvogel","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.021_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.021_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.immuni.2021.02.014","article-title":"Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery","volume":"54","author":"Chiou","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.08.021_bib20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.021_bib21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.chom.2026.02.010","article-title":"Leveraging intratumoral probiotics for pancreatic cancer immunotherapy via xenophagy","volume":"34","author":"Li","year":"2026","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2026.08.021_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","article-title":"Identification of bacteria-derived HLA-bound peptides in melanoma","volume":"592","author":"Kalaora","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.021_bib23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41587-023-01957-8","article-title":"Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses","volume":"42","author":"Wang","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2026.08.021_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.08.021_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10588","article-title":"Cancer vaccines in the clinic","volume":"9","author":"Janes","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.08.021_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamaoncol.2022.5370","article-title":"Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial","volume":"9","author":"Liau","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-020-00448-5","article-title":"Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer","volume":"6","author":"Ding","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.08.021_bib30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.aaa3828","article-title":"Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.021_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5931","article-title":"Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer","volume":"10","author":"Tanyi","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.08.021_bib32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.021_bib33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41591-020-0882-8","article-title":"Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer","volume":"26","author":"Roberti","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.021_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41571-018-0006-2","article-title":"The gut microbiota influences anticancer immunosurveillance and general health","volume":"15","author":"Routy","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12967-022-03512-6","article-title":"Molecular mimicry between tumor associated antigens and microbiota-derived epitopes","volume":"20","author":"Ragone","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.08.021_bib36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41586-023-06081-w","article-title":"Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma","volume":"617","author":"Naghavian","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.021_bib37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.critrevonc.2016.09.002","article-title":"Migration of dendritic cells to the lymph nodes and its enhancement to drive anti-tumor responses","volume":"107","author":"Seyfizadeh","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib38","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/cells15090752","article-title":"Trained Immunity in Neutrophils and Mononuclear Phagocytes: Mechanisms and Pathophysiological Functions","volume":"15","author":"Li","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2026.08.021_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature22383","article-title":"Quantifiable predictive features define epitope-specific T cell receptor repertoires","volume":"547","author":"Dash","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.021_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/B978-0-12-407190-2.00007-1","article-title":"Therapeutic cancer vaccines: past, present, and future","volume":"119","author":"Guo","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.021_bib41","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1200\/JCO.23.02585","article-title":"Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer","volume":"42","author":"van \u2018t Land","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib42","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2017-04-780155","article-title":"Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia","volume":"130","author":"Anguille","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.08.021_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40425-018-0330-1","article-title":"Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses","volume":"6","author":"Dillman","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.021_bib44","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1172\/JCI80009","article-title":"Therapeutic cancer vaccines","volume":"125","author":"Melief","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.08.021_bib45","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41591-019-0410-x","article-title":"Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination","volume":"25","author":"Hammerich","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.021_bib46","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-020-00143-y","article-title":"Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets","volume":"1","author":"Bhardwaj","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.021_bib47","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.021_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40425-017-0255-0","article-title":"Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma","volume":"5","author":"Laurell","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.021_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/357011a0","article-title":"Coley's toxins in perspective","volume":"357","author":"Starnes","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.021_bib50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib51","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","article-title":"Targeting the gut microbiota for cancer therapy","volume":"22","author":"Fernandes","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.021_bib52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-021-03986-2","article-title":"Unravelling the collateral damage of antibiotics on gut bacteria","volume":"599","author":"Maier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.021_bib53","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdy103","article-title":"Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer","volume":"29","author":"Derosa","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eururo.2020.04.044","article-title":"Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients","volume":"78","author":"Derosa","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib55","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jamaoncol.2019.2785","article-title":"Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer","volume":"5","author":"Pinato","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib56","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/d41591-023-00046-2","article-title":"First oral fecal microbiota transplant therapy approved","volume":"29","author":"Carvalho","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.021_bib57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/j.gastro.2023.03.222","article-title":"Transmission of the Potential Pathogen Atypical Enteropathogenic Escherichia coli by Fecal Microbiota Transplant","volume":"165","author":"Kralicek","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2026.08.021_bib58","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2021.06.009","article-title":"Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients","volume":"161","author":"Nooij","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2026.08.021_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102171","article-title":"Cross-reactivity between microbial and tumor antigens","volume":"75","author":"Zitvogel","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.19.1.1","article-title":"Specificity and degeneracy in antigen recognition: yin and yang in the immune system","volume":"19","author":"Eisen","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni891","article-title":"CDR3 loop flexibility contributes to the degeneracy of TCR recognition","volume":"4","author":"Reiser","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.021_bib62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm.4051","article-title":"Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients","volume":"22","author":"Gros","year":"2016","journal-title":"Nat. Med."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:36:56Z","timestamp":1787657816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":62,"alternative-id":["S1525001626007021"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DC vaccine loaded with Bacteroides fragilis elicits functional cross-reactivity and enhances anti-PD-1 immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}